March 31, 2017

Nektan PLC Interim Results for the six months ended 31 December 2016

Nektan PLC (LON:NKTN), a leading international B2B gaming solutions and services provider, announces its unaudited results for the six months ended 31 December 2016.   Financial Summary: Unaudited Unaudited Six..

Oxford BioMedica Delivering commercial gene-therapy vector

Oxford BioMedica plc (LON:OXB) is a specialist gene and cell therapy viral-vector biopharmaceutical company. It offers vector manufacturing and development services, whilst retaining its own proprietary therapeutic candidates. Above service-fees,..

Ilika plc Toyota brings AI into accelerated materials discovery with Ilika

On March 9th Ilika plc (LON:IKA) announced a $1m deal with its established blue chip partner Toyota Motor Corp (TYO:7203) in ‘a new application area’. Yesterday’s RNS reveals, via an..

Q&A with Falanx Group Ltd CEO Stuart Bladen: Launch of their platform ‘MidGARD’ (LON:FLX)

Falanx Group Ltd (LON:FLX) Chief Executive Officer Stuart Bladen caught up with DirectorsTalk for an exclusive interview to discuss the launch of MidGARD, the reasons for building their own platform,..

DX (Group) plc Proposed combination with Menzies’ Distribution and Interim results

DX (Group) plc (LON:DX) has announced that it is in discussion on a potential combination with the Distribution division of John Menzies. The proposed transaction would see DX acquire Menzies..

INTERVIEW: Widecells Group plc A cash generative, global proposition, all-star cast

Widecells Group plc (LON:WDC) CEO João Andrade talks to DirectorTalk about the company, how it plans to provide support advancements to the stem cell industry, the new laboratory in Manchester,..

Search

Funds

March 31, 2017

Search

Funds

March 31, 2017

FTSE 100

Funds